News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
New Enterprise Associates 14, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/09/2023 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Oyster Point Pharma, Inc. |
| 11/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/24/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/25/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 7.3% stake in IMARA Inc. |
| 01/10/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 14.1% stake in IMARA Inc. |
| 01/05/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Lumos Pharma, Inc. |
| 11/22/2021 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 15% stake in Casper Sleep Inc. |
| 03/10/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/10/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Mersana Therapeutics, Inc. |
| 11/19/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 5.8% stake in Mersana Therapeutics, Inc. |
| 09/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/24/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 12.9% stake in Mersana Therapeutics, Inc. |
| 05/14/2018 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for MuleSoft, Inc. |
| 04/03/2018 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 20% stake in Tracon Pharmaceuticals, Inc. |
| 02/01/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/07/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/16/2017 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 14.2% stake in Mirna Therapeutics, Inc. |
| 12/08/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/21/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 09/13/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
|
|